Safety and Immunogenicity of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Subgroup of Healthy Adults in Chile

Susan M. Bueno, Katia Abarca, Pablo A. González, Nicolás M.S. Gálvez, Jorge A. Soto, Luisa F. Duarte, Bárbara M. Schultz, Gaspar A. Pacheco, Liliana A. González, Yaneisi Vázquez, Mariana Ríos, Felipe Melo-González, Daniela Rivera-Pérez, Carolina Iturriaga, Marcela Urzúa, Angélica Domínguez, Catalina A. Andrade, Roslye V. Berríos-Rojas, Gisela Canedo-Marroquín, Camila CoviánDaniela Moreno-Tapia, Farides Saavedra, Omar P. Vallejos, Paulina Donato, Pilar Espinoza, Daniela Fuentes, Marcela González, Paula Guzmán, Paula Muñoz Venturelli, Carlos M. Pérez, Marcela Potin, Álvaro Rojas, Rodrigo A. Fasce, Jorge Fernández, Judith Mora, Eugenio Ramírez, Aracelly Gaete-Argel, Aarón Oyarzún-Arrau, Fernando Valiente-Echeverría, Ricardo Soto-Rifo, Daniela Weiskopf, Alessandro Sette, Gang Zeng, Weining Meng, José V. González-Aramundiz, Alexis M. Kalergis

Research output: Contribution to journalArticlepeer-review

54 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Safety and Immunogenicity of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Subgroup of Healthy Adults in Chile'. Together they form a unique fingerprint.

Medicine & Life Sciences